{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T18:43:02Z","timestamp":1747420982501},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,21]]},"DOI":"10.7759\/cureus.35277","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T23:12:41Z","timestamp":1677021161000},"source":"Crossref","is-referenced-by-count":1,"title":["Thrombospondin Type 1 Domain-Containing 7A (THSD7A)-Associated Membranous Nephropathy Leading to Metastatic Neuroendocrine Carcinoma"],"prefix":"10.7759","author":[{"given":"Angel","family":"Juarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidice","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Ragunathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Gondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07190717","article-title":"Primary membranous nephropathy [published correction]","volume":"12","author":"Couser WG","year":"2017","unstructured":"Couser WG. Primary membranous nephropathy [published correction]. Clin J Am Soc Nephrol. 2017, 12:1528. 10.2215\/CJN.07190717","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.07.014","article-title":"The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a\u00a0decade after its discovery","volume":"96","author":"van de Logt AE","year":"2019","unstructured":"van de Logt AE, Fresquet M, Wetzels JF, Brenchley P. The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a\u00a0decade after its discovery. Kidney Int. 2019, 96:1292-302. 10.1016\/j.kint.2019.07.014","journal-title":"Kidney Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2018.1456457","article-title":"An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN","volume":"40","author":"Ren S","year":"2018","unstructured":"Ren S, Wu C, Zhang Y, Wang AY, Li G, Wang L, Hong D. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN. Ren Fail. 2018, 40:306-13. 10.1080\/0886022X.2018.1456457","journal-title":"Ren Fail"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199807000-00004","article-title":"Low anion gap","volume":"91","author":"Jurado RL","year":"1998","unstructured":"Jurado RL, del Rio C, Nassar G, Navarette J, Pimentel JL Jr. Low anion gap. South Med J. 1998, 91:624-9. 10.1097\/00007611-199807000-00004","journal-title":"South Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11761116","article-title":"Primary Membranous Nephropathy","volume":"12","author":"Couser WG","year":"2017","unstructured":"Couser WG. Primary Membranous Nephropathy. Clin J Am Soc Nephrol. 2017, 12:983-97. 10.2215\/CJN.11761116","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/128262-thrombospondin-type-1-domain-containing-7a-thsd7a-associated-membranous-nephropathy-leading-to-metastatic-neuroendocrine-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:35Z","timestamp":1707508295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/128262-thrombospondin-type-1-domain-containing-7a-thsd7a-associated-membranous-nephropathy-leading-to-metastatic-neuroendocrine-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.35277","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,21]]}}}